Michael A Kamm
#97,624
Most Influential Person Now
Researcher
Michael A Kamm's AcademicInfluence.com Rankings
Michael A Kammchemistry Degrees
Chemistry
#1609
World Rank
#2373
Historical Rank
Chemical Engineering
#115
World Rank
#128
Historical Rank

Download Badge
Chemistry
Michael A Kamm's Degrees
- PhD Chemical Engineering University of California, Berkeley
- Masters Chemical Engineering University of California, Berkeley
- Bachelors Chemical Engineering University of California, Berkeley
Why Is Michael A Kamm Influential?
(Suggest an Edit or Addition)Michael A Kamm's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Infliximab maintenance therapy for fistulizing Crohn's disease. (2004) (2059)
- Anal-sphincter disruption during vaginal delivery. (1993) (1588)
- Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. (2004) (1178)
- Prospective comparison of faecal incontinence grading systems (1999) (1149)
- Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine (2004) (989)
- Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis (2003) (903)
- Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial (2017) (807)
- Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair (1994) (726)
- Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. (2013) (645)
- Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. (2006) (633)
- Mechanisms of action of probiotics: Recent advances (2009) (588)
- Modulation of human dendritic cell phenotype and function by probiotic bacteria (2004) (565)
- A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. (2005) (564)
- Characteristics of intestinal dendritic cells in inflammatory bowel diseases. (2005) (518)
- Development of the Crohn's disease digestive damage score, the Lémann score (2010) (511)
- Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. (1993) (483)
- Myths and Misconceptions About Chronic Constipation (2005) (476)
- Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease (1994) (469)
- Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma (2000) (450)
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response? (2011) (440)
- Crohn's disease management after intestinal resection: a randomised trial (2015) (436)
- Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk (2004) (411)
- Pudendal nerve damage during labour: prospective study before and after childbirth * (1994) (404)
- AGA technical review on anorectal testing techniques. (1999) (372)
- Randomized controlled trial of biofeedback for fecal incontinence. (2003) (371)
- Once-daily, high-concentration MMX mesalamine in active ulcerative colitis. (2007) (353)
- Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease (1997) (342)
- Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease (2005) (341)
- Bowel dysfunction in spinal-cord-injury patients (1996) (332)
- Obstetric damage and faecal incontinence (1994) (328)
- Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study (2005) (320)
- Obstetric Anal Sphincter Injury: Incidence, Risk Factors, and Management (2008) (316)
- Most dysplasia in ulcerative colitis is visible at colonoscopy. (2004) (315)
- Intestinal dendritic cells increase T cell expression of α4β7 integrin (2002) (311)
- Sacral spinal nerve stimulation for faecal incontinence: multicentre study (2004) (310)
- Inflammatory bowel disease in Asia: A systematic review (2012) (308)
- Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). (1998) (298)
- A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease (2014) (297)
- Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific (2014) (297)
- Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease (2011) (285)
- Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis. (2007) (275)
- Diagnosis and treatment of chronic constipation – a European perspective (2011) (273)
- Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis (2017) (268)
- Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. (2019) (249)
- Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis (2006) (249)
- Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease. (2015) (247)
- Outcome of colectomy for severe idiopathic constipation. (1988) (246)
- Sacral nerve stimulation for intractable constipation (2010) (244)
- Bowel dysfunction: a pathogenic factor in uterovaginal prolapse and urinary stress incontinence (1994) (242)
- An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. (2001) (242)
- Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery. (2015) (241)
- The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria (2003) (236)
- A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation (2008) (229)
- American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. (2007) (226)
- Double-blind randomised controlled trial of effect of metronidazole on pain after day-case haemorrhoidectomy (1998) (224)
- Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults (1997) (220)
- Randomised controlled trial shows that glyceryl trinitrate heals anal fissures, higher doses are not more effective, and there is a high recurrence rate (1999) (212)
- Prospective study of the extent of internal anal sphincter division during lateral sphincterotomy (1994) (210)
- Primary degeneration of the internal anal sphincter as a cause of passive faecal incontinence (1997) (206)
- Permanent sacral nerve stimulation for fecal incontinence. (2000) (206)
- Relationship of symptoms in faecal incontinence to specific sphincter abnormalities (2004) (191)
- Tegaserod for the Treatment of Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Multinational Study (2005) (190)
- Review article: defining remission in ulcerative colitis (2011) (190)
- Biofeedback provides long term benefit for patients with intractable, slow and normal transit constipation (1998) (190)
- Persistent pain and faecal urgency after stapled haemorrhoidectomy (2000) (186)
- High incidence of inflammatory bowel disease in Australia: A prospective population‐based Australian incidence study (2010) (186)
- Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis (2008) (182)
- Recent Advances in Characterizing the Gastrointestinal Microbiome in Crohn's Disease: A Systematic Review (2015) (180)
- Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota* (2012) (176)
- Endosonography of the anal sphincters: normal anatomy and comparison with manometry. (1994) (175)
- Migration and Maturation of Human Colonic Dendritic Cells (2001) (174)
- Postoperative recurrent luminal Crohn's disease: a systematic review. (2012) (173)
- Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. (2002) (172)
- Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review (2012) (171)
- Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. (1994) (171)
- Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. (2004) (169)
- Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn's Perineal Fistulas (2009) (168)
- Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. (1996) (165)
- Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging (2003) (165)
- Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting (2020) (164)
- Rectal mucosal electrosensory testing—Evidence for a rectal sensory neuropathy in idiopathic constipation (1990) (162)
- Lower gastrointestinal malignancy in Crohn's disease. (1994) (161)
- Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Sodium Picosulfate in Patients With Chronic Constipation (2010) (159)
- Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. (2011) (159)
- Topical glyceryl trinitrate in the treatment of chronic anal fissure (1996) (159)
- Genetics of inflammatory bowel disease in Asia: Systematic review and meta‐analysis (2011) (159)
- Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. (1992) (157)
- A comparison between electromyography and anal endosonography in mapping external anal sphincter defects (1990) (157)
- Double-blind crossover study of sacral nerve stimulation for fecal incontinence (2000) (154)
- Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects (2000) (154)
- Mucosal Healing in Crohn's Disease: A Systematic Review (2013) (151)
- Urbanization and the gut microbiota in health and inflammatory bowel disease (2018) (150)
- Unsuspected sphincter damage following childbirth revealed by anal endosonography. (1991) (147)
- A Randomized, Controlled Trial of Diathermy Hemorrhoidectomy vs. Stapled Hemorrhoidectomy in an Intended Day-Care Setting With Longer-Term Follow-Up (2003) (145)
- Transperineal repair of symptomatic rectocele with Marlex mesh: a clinical, physiological and radiologic assessment of treatment. (1996) (144)
- Three‐dimensional endoanal sonography in assessing anal canal injury (1999) (141)
- Gastrointestinal transit and prolonged ambulatory colonic motility in health and faecal incontinence (1997) (140)
- Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. (1997) (136)
- Prucalopride, a systemic enterokinetic, for the treatment of constipation (2002) (133)
- Association between specific mucosa‐associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study (2015) (130)
- Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. (1990) (129)
- Mechanisms of initiation and perpetuation of gut inflammation by stress (2002) (128)
- Sacral nerve stimulation for faecal incontinence due to systemic sclerosis (2002) (127)
- Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific (2018) (125)
- Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis (2010) (125)
- Controlled randomised trial of visual biofeedback versus muscle training without a visual display for intractable constipation. (1995) (125)
- Proctographic features of anismus. (1995) (124)
- Hereditary internal anal sphincter myopathy causing proctalgia fugax and constipation. A newly identified condition. (1991) (123)
- Obstetric perineal trauma: An audit of training (1995) (122)
- Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction (2004) (121)
- Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation (2001) (120)
- Effect of probiotic strains on interleukin 8 production by HT29/19A cells (2002) (117)
- Use of Probiotics in the Treatment of Inflammatory Bowel Disease (2003) (115)
- Long‐term MRI‐guided combined anti‐TNF‐&agr; and thiopurine therapy for crohn's perianal fistulas (2012) (115)
- Donor Recruitment for Fecal Microbiota Transplantation (2015) (114)
- Pathophysiology and management of bowel dysfunction in multiple sclerosis (2001) (113)
- Adverse Effects of Drugs Used in the Management of Constipation and Diarrhoea (1994) (113)
- Fortnightly review : Faecal incontinence (1998) (111)
- Clinical, physiological, and radiological study of a new purpose-designed artificial bowel sphincter. (1998) (110)
- The normal range and a simple diagram for recording whole gut transit time (1992) (110)
- First Prospective, Population-Based Inflammatory Bowel Disease Incidence Study in Mainland of China: The Emergence of “Western” Disease (2013) (109)
- Topical tacrolimus in the treatment of perianal Crohn's disease: Exploratory randomized controlled trial (2007) (109)
- Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. (1993) (108)
- Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease (2011) (108)
- Prospective assessment of accuracy of endoanal MR imaging and endosonography in patients with fecal incontinence. (2000) (107)
- Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'. (1993) (106)
- Patients’ Views of a Colostomy for Fecal Incontinence (2005) (106)
- Adalimumab for the treatment of fistulas in patients with Crohn’s disease (2009) (106)
- Relationship between anatomic and symptomatic long-term results after rectocele repair for impaired defecation (1999) (106)
- Female anal sphincter: age-related differences in asymptomatic volunteers with high-frequency endoanal US. (2002) (105)
- Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting (2003) (105)
- Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers (1998) (104)
- Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis (2000) (104)
- Clinical features of idiopathic megarectum and idiopathic megacolon. (1997) (104)
- Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis (2015) (102)
- Preliminary examination of the relations between disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn's disease guided by the common sense model of illness (2011) (102)
- Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials. (2014) (100)
- Topical diltiazem and bethanechol decrease anal sphincter pressure without side effects (1999) (100)
- Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease (2009) (100)
- Sacral Nerve Stimulation for Fecal Incontinence Related to Obstetric Anal Sphincter Damage (2008) (100)
- Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. (1997) (99)
- Internal anal sphincter augmentation for fecal incontinence using injectable silicone biomaterial (2001) (98)
- Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence (2001) (98)
- Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. (2016) (96)
- Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease (2012) (96)
- Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron). (1996) (94)
- Injectable silicone biomaterial for faecal incontinence due to internal anal sphincter dysfunction (2002) (94)
- DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. (1997) (92)
- Ghrelin for the gastroenterologist: history and potential. (2003) (91)
- Effect of extended MMX mesalamine therapy for acute, mild‐to‐moderate Ulcerative Colitis (2009) (91)
- Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial (2009) (89)
- Disability in inflammatory bowel diseases: Developing ICF core sets for patients with inflammatory bowel diseases based on the international classification of functioning, disability, and health (2010) (89)
- Dynamics of the Mucosa-Associated Flora in Ulcerative Colitis Patients during Remission and Clinical Relapse (2008) (88)
- Serotonin and 5-hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation. (1990) (88)
- Proteus spp. as Putative Gastrointestinal Pathogens (2018) (87)
- Bowel function and transit rate during the menstrual cycle. (1989) (87)
- Does the St. Mark’s Incontinence Score Reflect Patients’ Perceptions? A Review of 390 Patients (2008) (86)
- Internal anal sphincter repair (1997) (85)
- Long-Term Results of Repeat Anterior Anal Sphincter Repair (2004) (85)
- Predictive value of impaired evacuation at proctography in diagnosing anismus. (2001) (84)
- Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence. (1994) (83)
- Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study (2011) (82)
- Antibodies to tumour necrosis factor α as treatment for Crohn's disease (2000) (82)
- Impact of Ethnicity, Geography, and Disease on the Microbiota in Health and Inflammatory Bowel Disease (2013) (81)
- Decreased density of interstitial cells of Cajal and neuronal cells in patients with slow‐transit constipation and acquired megacolon (2005) (80)
- Laser Doppler measurement of rectal mucosal blood flow (1999) (80)
- Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis. (2020) (79)
- Systematic review with meta‐analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation (2019) (78)
- Short-term effects of sacral nerve stimulation for idiopathic slow transit constipation. (2002) (78)
- Prospective evaluation of the treatment of solitary rectal ulcer syndrome with biofeedback (1997) (76)
- Intestinal dendritic cells: Their role in bacterial recognition, lymphocyte homing, and intestinal inflammation (2010) (75)
- Chromoendoscopy versus Narrow Band Imaging for Colonic Surveillance in Inflammatory Bowel Disease (2013) (75)
- Medium‐term results of oral tacrolimus treatment in refractory inflammatory bowel disease (2007) (74)
- Therapeutic strategies for the management of ulcerative colitis (2009) (73)
- Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome (2013) (73)
- Microbial Factors Associated with Postoperative Crohn’s Disease Recurrence (2017) (73)
- Randomized, Controlled Trial of Anal Electrical Stimulation for Fecal Incontinence (2006) (73)
- Management of Postoperative Crohn's Disease (2008) (73)
- Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity. (2004) (72)
- Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE) (2019) (72)
- Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease (2000) (72)
- Psychological state and quality of life in patients having behavioral treatment (biofeedback) for intractable constipation (2002) (71)
- Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases (2020) (71)
- Incontinence: Causes, Management and Provision of Services (1995) (68)
- Pathophysiology of diverticular disease. (2002) (67)
- Disturbed gastric and small bowel transit in severe idiopathic constipation (1993) (66)
- Up-Regulation of Collagen and Tissue Inhibitors of Matrix Metalloproteinase in Colonic Diverticular Disease (2004) (66)
- Sacral nerve stimulation for faecal incontinence following a rectosigmoid resection for colorectal cancer (2005) (66)
- Dynamic scanning defines a colonic defect in severe idiopathic constipation. (1988) (66)
- Cinical, physiological, and radiological study of a new purpose-designed artifical bowel sphincter (1998) (66)
- Vaginal endosonography (1994) (65)
- Relationship between psychological state and level of activity of extrinsic gut innervation in patients with a functional gut disorder (2001) (65)
- Abdominal rectopexy for complete prolapse: Prospective study evaluating changes in symptoms and anorectal function (1992) (64)
- Visceral adiposity predicts post‐operative Crohn's disease recurrence (2017) (64)
- Colectomy for idiopathic megarectum and megacolon. (1991) (63)
- Behavioural therapy (biofeedback) for solitary rectal ulcer syndrome improves symptoms and mucosal blood flow (2004) (62)
- Gender differences in the longitudinal pressure profile of the anal canal related to anatomical structure as demonstrated on three‐dimensional anal endosonography (2000) (62)
- Magnetic resonance imaging of the pelvic floor in patients with obstructed defaecation (1997) (62)
- Results of behavioral treatment (biofeedback) for solitary rectal ulcer syndrome (2001) (62)
- Pathology of idiopathic megarectum and megacolon (1997) (61)
- Randomized, controlled trial of topical phenylephrine for fecal incontinence in patients after ileoanal pouch construction (2000) (60)
- MMX mesalazine for the induction of remission of mild‐to‐moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations (2008) (59)
- Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness (2017) (59)
- Perianal fistulizing Crohn's disease: a call to action. (2008) (59)
- Rapid changes in epidemiology of inflammatory bowel disease (2017) (58)
- Treatment of impaired defecation associated with rectocele by behavioral retraining (biofeedback) (2000) (58)
- Review article: the psychoneuroimmunology of irritable bowel syndrome – an exploration of interactions between psychological, neurological and immunological observations (2008) (58)
- The effect of Khat (Catha edulis) as an appetite suppressant is independent of ghrelin and PYY secretion (2008) (58)
- Colorectal and anal motility during defaecation (1992) (58)
- Prospective study of biofeedback treatment for patients with slow and normal transit constipation (1994) (58)
- A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease (2016) (57)
- Proctocolectomy with restorative ileoanal reservoir for severe idiopathic constipation (1988) (57)
- Psychological morbidity in women with idiopathic constipation (2000) (56)
- Observation on the characteristics of stimulated defaecation in severe idiopathic constipation (1992) (55)
- Sacral Nerve Stimulation for Fecal Incontinence Following Surgery for Rectal Prolapse Repair: A Multicenter Study (2005) (55)
- Impact of Drug Therapy and Surgery on Quality of Life in Crohn's Disease: A Systematic Review (2015) (55)
- Effect of probiotic strains on interleukin 8 production by HT29/19A cells. (2002) (55)
- Prospective Assessment of the Clinical Value of Anorectal Investigations (2000) (54)
- Transvaginal Versus Anal Endosonography for Detecting Damage to the Anal Sphincter (1997) (53)
- Survey of laxative use by adults with self‐defined constipation in South America and Asia: a comparison of six countries (2009) (53)
- Prospective assessment of the effect on quality of life of anti‐tumour necrosis factor therapy for perineal Crohn’s fistulas (2009) (52)
- Pathology of the rectal wall in solitary rectal ulcer syndrome and complete rectal prolapse. (1996) (52)
- Topical phenylephrine increases anal sphincter resting pressure (1999) (50)
- Long‐term results of low‐dose intravenous ciclosporin for acute severe ulcerative colitis (2003) (50)
- Clinical and surgical recurrence of Crohn's disease after ileocolonic resection in a specialist unit (2009) (50)
- Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study (2001) (50)
- Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. (2000) (49)
- Peptide-containing neurons in different regions of the submucous plexus of human sigmoid colon. (1992) (49)
- Assessment of External Anal Sphincter Morphology in Idiopathic Fecal Incontinence with Endocoil Magnetic Resonance Imaging (2001) (47)
- Abnormal visceral autonomic innervation in neurogenic faecal incontinence. (1993) (47)
- Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. (2020) (47)
- Steroid hormone abnormalities in women with severe idiopathic constipation. (1991) (47)
- Fecal Biomarkers in the Diagnosis and Monitoring of Crohn's Disease (2014) (46)
- Review article: population screening for colorectal cancer (2005) (45)
- Effect of pregnancy on anal sphincter morphology and function (1993) (45)
- Short-term Effects of Sacral Nerve Stimulation for IdiopathicSlow Transit Constipation (2002) (45)
- Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice (2020) (45)
- Faecal incontinence after childbirth (1997) (45)
- A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn's disease (2012) (45)
- Dietary Guidance for Patients with Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease. (2020) (44)
- The acute effect of straining on pelvic floor neurological function (1994) (44)
- Defined microbiota transplant restores Th17/RORγt+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas (2019) (44)
- Enkephalins modulate inhibitory neuromuscular transmission in circular muscle of human colon via delta‐opioid receptors. (1990) (43)
- Adalimumab sustains steroid‐free remission after 3 years of therapy for Crohn’s disease (2011) (43)
- Constipation and its management (2003) (43)
- Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation (2007) (42)
- Idiopathic slow-transit constipation: an almost exclusively female disorder (2003) (42)
- Circulating Gastrointestinal Hormone Abnormalities in Patients With Severe Idiopathic Constipation (1998) (42)
- Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohort (2015) (42)
- Sacral nerve stimulation for the treatment of faecal incontinence related to dysfunction of the internal anal sphincter (2010) (41)
- Safety, Tolerability, and Efficacy of Tegaserod over 13 Months in Patients with Chronic Constipation (2006) (41)
- Abnormal internal anal sphincter fibrosis and elasticity in fecal incontinence (1995) (41)
- Predictive value and clinical significance of myenteric plexitis in Crohn's disease (2009) (40)
- Internal anal sphincter myopathy causing proctalgia fugax and constipation: further clinical and radiological characterization in a patient. (1997) (39)
- Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation. (2020) (39)
- Non-surgical management of faecal incontinence. (2001) (39)
- Development and validation of a patient‐reported disability measurement tool for patients with inflammatory bowel disease (2013) (38)
- Prospective assessment of interobserver agreement for endoanal MRI in fecal incontinence (2001) (38)
- Changes in anal anatomy following vaginal delivery revealed by anal endosonography (1999) (37)
- Long-term outcome of sacral neuromodulation for chronic refractory constipation (2017) (37)
- Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti‐tumor necrosis factor monotherapy (2013) (37)
- Perineal examination as a predictor of underlying external anal sphincter damage (1997) (37)
- Psychological well-being and quality of life in Crohn's disease patients with an ostomy: a preliminary investigation. (2013) (37)
- Anorexia nervosa in gastrointestinal practice (2004) (36)
- Faecal incontinence (2003) (36)
- Influence of the subpubic arch angle on anal sphincter trauma and anal incontinence following childbirth (2002) (35)
- Dynamic cystoproctography and physiological testing in women with urinary stress incontinence and urogenital prolapse. (1996) (34)
- Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne (2012) (34)
- Diagnostic Evaluation of Patients with Faecal Incontinence at a Specialist Institution (2004) (33)
- The internal and sphincter--new insights into faecal incontinence. (1991) (32)
- Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease. (2018) (32)
- Partial colectomy and coloanal anastomosis for idiopathic megarectum and megacolon (1992) (32)
- The Role of CT Colonography in Colorectal Cancer Screening (2005) (32)
- Gastroenterologist perceptions of faecal microbiota transplantation. (2015) (32)
- Perineal damage at delivery (1994) (31)
- Randomised controlled trial of metronidazole to reduce pain after day case haemorrhoidectomy (1998) (31)
- Chronic pelvic pain in women – gastroenterological, gynaecological or psychological? (1997) (31)
- Exploration of Health Status, Illness Perceptions, Coping Strategies, and Psychological Morbidity in Stoma Patients (2014) (31)
- The anal sphincter in idiopathic megarectum (1996) (31)
- Quantitative and functional characteristics of intestinal‐homing memory T cells: analysis of Crohn's disease patients and healthy controls (2004) (31)
- Evaluation of the intrinsic innervation of the internal anal sphincter using electrical stimulation. (1989) (30)
- Reassessing artificial bowel sphincters (2000) (29)
- Pilot study of two new injectable bulking agents for the treatment of faecal incontinence. (2008) (29)
- Effect of intestinal resection on quality of life in Crohn's disease. (2015) (29)
- Morbidity, mortality, and risk factors for esophagitis in hospital inpatients. (2000) (29)
- Review article: maintenance of remission in ulcerative colitis. (2002) (28)
- Contribution of gastrointestinal transit and pouch characteristics in determining pouch function. (1997) (27)
- Asian perspectives in the management of inflammatory bowel disease: Findings from a recent survey (2010) (27)
- Predictors for developing intestinal failure in patients with Crohn's disease (2013) (27)
- Unwanted anal penetration as a physical cause of faecal incontinence. (1995) (26)
- Permanent Sacral Nerve Stimulation for Treatment of Functional Anorectal Pain: Report of a Case (2007) (26)
- Reproducible assessment of vaginal and rectal mucosal and skin blood flow: laser doppler fluximetry of the pelvic microcirculation. (2000) (26)
- Electrogastrography in chronic intestinal pseudoobstruction (1996) (26)
- Cancer surveillance strategies in ulcerative colitis: The need for modernization (2011) (26)
- Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis (2008) (25)
- Enteric innervation in idiopathic megarectum and megacolon (1996) (25)
- Examination techniques for endosonography of the anal canal (1998) (24)
- Inflammatory bowel disease in Asia (2010) (24)
- 925j Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study. (2013) (24)
- Oesophageal epithelial innervation in health and reflux oesophagitis (1999) (24)
- A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective (2010) (23)
- Solitary rectal ulcer and complete rectal prolapse: one condition or two? (2004) (23)
- Practical application of anti‐TNF therapy for luminal Crohn's disease (2011) (22)
- Fecal microbiota transplantation therapy in Crohn's disease: Systematic review (2021) (22)
- OP023 Optimising post-operative Crohn's disease management: Best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study (2014) (22)
- Inflammatory bowel disease serology in Asia and the West. (2013) (22)
- A novel population of human CD56+ human leucocyte antigen D‐related (HLA‐DR+) colonic lamina propria cells is associated with inflammation in ulcerative colitis (2009) (22)
- Relationship between gut-specific autonomic testing and bowel dysfunction in spinal cord injury patients (2009) (22)
- Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics (1987) (22)
- Comparison of Fecal Inflammatory Markers in Crohn's Disease (2016) (21)
- 1161 Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study (2012) (21)
- 600 Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial (2016) (21)
- Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure (2020) (21)
- Diagnostic, pharmacological, surgical and behavioural developments in benign anorectal disease. (2003) (20)
- Gastrointestinal transit in patients with idiopathic megarectum (1996) (20)
- Intractable vomiting due to a brainstem lesion in the absence of neurological signs or raised intracranial pressure (1998) (20)
- Recent developments in CT colonography. (2005) (20)
- Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn’s Disease (2018) (20)
- Prospective Evaluation of Intestinal Homing Memory T Cells in Ulcerative Colitis (2004) (20)
- Review article: the management of constipation in adults. (1993) (19)
- Thiopurine metabolite testing in inflammatory bowel disease (2016) (19)
- The design of a two‐phase radiolabelled meal for gastric emptying studies (1991) (19)
- Serologic antibodies in relation to outcome in postoperative Crohn's disease (2017) (19)
- Sodium picosulfate in opioid-induced constipation: results of an open-label, prospective, dose-ranging study (2006) (19)
- Diltiazem lowers resting anal sphincter pressure: A potential low side-effect alternative to glycerl trinitrate (GTN) for fissures (1998) (18)
- Specialist nurses in gastroenterology. (2002) (18)
- Noninvasive imaging of the small bowel in Crohn's disease: The final frontier (2011) (18)
- Constipation. Etiology, Evaluation and Management (1995) (18)
- Comparison of Clinical Outcome Between Open and Percutaneous Lead Insertion for Permanent Sacral Nerve Neurostimulation for the Treatment of Fecal Incontinence (2009) (17)
- Behavioural treatment (biofeedback) for constipation following hysterectomy (2000) (17)
- Bowel dysfunction in young women with urinary retention. (1993) (17)
- Left hemicolectomy with rectal excision for severe idiopathic constipation (1991) (17)
- S1321 Stimulant Laxatives are Effective in Chronic Constipation: Multi-Center, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Bisacodyl (2010) (17)
- Joint symptoms after restorative proctocolectomy in ulcerative colitis and familial polyposis coli. (1996) (17)
- Sphincteroplasty for incontinence after surgery for idiopathic fistula in ano (1997) (17)
- Exploration of Health Status, Illness Perceptions, Coping Strategies, Psychological Morbidity, and Quality of Life in Individuals With Fecal Ostomies (2017) (16)
- Role of surgical treatment in patients with severe constipation. (1990) (16)
- Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice (2014) (16)
- Clinical case: chronic constipation. (2006) (16)
- The small intestine and colon: scintigraphic quantitation of motility in health and disease (2004) (16)
- Corrigendum: The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response? (2011) (16)
- The role of psychosocial factors in functional gut disease. (1998) (16)
- Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes. (2019) (16)
- Faecal incontinence: common and treatable (2002) (15)
- Adalimumab prevents post-operative Crohn's disease recurrence, and is superior to thiopurines: early results from the POCER study (2012) (15)
- Results of stoma formation for idiopathic megarectum and megacolon (1992) (15)
- Systematic review of the efficacy and safety of sacral nerve stimulation for faecal incontinence (2003) (15)
- Distinct neurophysiological profiles in irritable bowel syndrome. (2011) (15)
- Diet and gut microbiome in gastrointestinal disease (2021) (15)
- A randomized controlled trial of CDP571, a humanized antibody to TNFA, in moderately to severely active Crohn's disease (2000) (14)
- Dysplastic lesions in ulcerative colitis: Changing paradigms (2010) (14)
- Gastrointestinal Transit: Pathophysiology and Pharmacology (1991) (14)
- Luminal microbiota related to Crohn’s disease recurrence after surgery (2020) (14)
- Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo‐obstruction (2018) (14)
- Bowel Control : Information and Practical Advice (1998) (13)
- Outcome of hospital outpatient treatment of functional gastrointestinal disorders (2019) (13)
- Symptomatic Gastroesophageal Reflux in Acutely Hospitalized Patients (2004) (13)
- Drug management of ulcerative colitis. (1992) (13)
- Assessment of the Predictive Value of a Bowel Symptom Questionnaire in Identifying Perianal and Anal Sphincter Trauma After Vaginal Delivery (2003) (13)
- Pudendal Nerve Stimulation for Bowel Dysfunction in Complete Cauda Equina Syndrome (2014) (12)
- Rectodynamics — quantifying rectal evacuation (1989) (12)
- Differences Across Illness Perceptions in Inflammatory Bowel Disease and Their Relationships to Psychological Distress and Quality of Life (2017) (12)
- Mesalamine with MMX™ technology for the treatment of ulcerative colitis (2008) (12)
- Why the enteric nervous system is important to clinicians (2000) (12)
- Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures (2020) (11)
- Psychological morbidity in women with idiopathic constipation. (2000) (11)
- Comparison of the Efficacy and Safety of SPD476, a Novel, Once-Daily, High-Dose Formulation of Mesalamine, and Asacol with Placebo for the Induction of Remission of Mild-Moderate Ulcerative Colitis: A Phase III Study (2005) (11)
- Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease. (2018) (11)
- Novel strain-level resolution of Crohn’s disease mucosa-associated microbiota via an ex vivo combination of microbe culture and metagenomic sequencing (2021) (11)
- The effect of an antacid and food on the absorption of cimetidine and ranitidine (1990) (11)
- Working Party report: defecation disorders. (1994) (11)
- Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease (2016) (11)
- Delivery of care for functional gastrointestinal disorders: A systematic review (2020) (11)
- Long Term Outcome of Multidisciplinary versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders. A Randomised Trial. (2021) (10)
- Pemphigus vulgaris of the esophagus. (1988) (10)
- MMX Mesalamine for Induction and Maintenance Therapy in Mild-to-Moderate Ulcerative Colitis (2009) (10)
- Ghrelin enhances gastric emptying in diabetic gastroparesis (2005) (10)
- Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates (2021) (10)
- Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial. (2021) (10)
- Quality of life in reflux and dyspepsia. Development and psychometric documentation of a disease-specific questionnaire (QOLRAD) (1998) (10)
- Cost-effectiveness of Crohn's disease post-operative care. (2016) (10)
- Relapsing eosinophilic myositis--a cause of pseudothrombophlebitis in an alcoholic. (1987) (10)
- Ultrasonography shows no abnormality of pelvic structures in women with severe idiopathic constipation. (1989) (10)
- Investigation of faecal incontinence. (2001) (9)
- SPD476 Is a Novel, Once-Daily, High-Dose, Effective and Well Tolerated 5ASA Formulation for the Induction of Remission of Mild-to-Moderate Ulcerative Colitis: A Phase III Study (2005) (9)
- 78 Incidence and Phenotype of Inflammatory Bowel Disease From 13 Countries in Asia-Pacific: Results From the Asia-Pacific Crohn's and Colitis Epidemiologic Study 2011-2013 (2016) (9)
- Prucalopride (PRU) improves colonic transit and stool frequency in patients (PTS) with slow and normal transit constipation (2000) (9)
- Entry criteria for drug trials of irritable bowel syndrome. (1999) (9)
- Tu1164 Environmental Risk Factors in Inflammatory Bowel Disease in Asia-Pacific: A Population-Based Case-Control Study (2014) (9)
- Surgery for idiopathic megarectum and megacolon (1991) (9)
- Fecal incontinence. (2001) (9)
- The gut microbiota: cause and cure of gut diseases (2018) (9)
- Low dose interferon gamma for refractory Crohn's disease. (1997) (9)
- Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn ' s Disease Following Surgery (2015) (9)
- Outcome of behavioural treatment for idiopathic chronic constipation (2014) (8)
- Novel drug therapies in inflammatory bowel disease. (1995) (8)
- M1202 Effective Probiotic Treatment (VSL#3), But Not Placebo, in Acute Ulcerative Colitis Is Associated with Down-Regulation of Inflammatory Intestinal Dendritic Cells (2008) (8)
- An extra-ordinary cause of megacolon (1997) (8)
- Prevalence of disordered eating in adults with gastrointestinal disorders: A systematic review (2021) (8)
- Bisacodyl and Sodium Picosulfate Improve Bowel Function and Quality of Life in Patients with Chronic Constipation—Analysis of Pooled Data from Two Randomized Controlled Trials (2017) (8)
- Efficacy of drug and endoscopic treatment of Crohn's disease strictures: A systematic review (2020) (8)
- Review article: chronic active disease and maintaining remission in Crohn's disease. (2004) (8)
- W1096 Results from An Open-Label Extension of CHARM: Steroid-Free Remission in Patients with Crohn's Disease Who Received Adalimumab Therapy for At Least 3 Years (2009) (7)
- Evaluation of specific herpes DNA viruses in idiopathic megarectum and idiopathic megacolon (1998) (7)
- Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy (2020) (7)
- Primary and secondary disorders to gut muscle and nerve. (1996) (7)
- Pharmacological treatment of irritable bowel syndrome--from concept to sales. (2002) (7)
- Endoscopic Prediction of Crohn's Disease Postoperative Recurrence. (2021) (7)
- Faecal incontinence. (1998) (7)
- Gastric Compliance, Sensation, and the Relaxation Response to a Nitric Oxide Donor in Health and Reflux Oesophagitis (1999) (7)
- A global consensus on the classi fi cation , diagnosis and multidisciplinary treatment of perianal fi stulising Crohn ’ s disease (2014) (6)
- Tegaserod is effective in relieving the multiple symptoms of constipation: results from a 12-week multinational study in patients with chronic constipation (2003) (6)
- The value of age of onset and rectal emptying in predicting the outcome of colectomy for severe idiopathic constipation (1992) (6)
- Idiopathic constipation: any movement? (1992) (6)
- Surgical management of severe idiopathic constipation: a review. (1991) (6)
- Psychological Well-Being and Quality of Life in Crohn's Disease Patients With an Ostomy: A Preliminary Investigation (2013) (6)
- Fulminant Crohn's colitis: When only an antibody will do (2007) (6)
- Debate: Should Mesalamine Be Used in Crohn's Disease?: Comments and Conclusions (2005) (6)
- Pharmacological modulation of gut mucosal and large vessel blood flow (2007) (6)
- Intestinal pseudo-obstruction (2000) (6)
- Magnification pan-chromoendoscopy remains the mainstay for colitis dysplasia detection and differentiation. (2007) (6)
- Simple water‐based tacrolimus enemas for refractory proctitis (2019) (6)
- Su2092 Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study (2012) (6)
- Systematic review: Pelvic floor muscle training for functional bowel symptoms in inflammatory bowel disease (2019) (5)
- Telehealth model of care for outpatient inflammatory bowel disease care in the setting of the COVID‐19 pandemic (2021) (5)
- Glyceryl trinitrate heals anal fissures, high doses do it quicker, but there is a high recurrence rate (1998) (5)
- A prospective clinical, physiological and radiological study of anew purpose-designed artificial bowel sphincter (1998) (5)
- Sustainability of Adalimumab in Fistula Healing and Response: 2-Year Data from CHARM and 12-Month Open-Label Extension Follow-Up Study: 1034 (2007) (5)
- A Case of Factitious Colonic Bleeding (1990) (5)
- Processed food affects the gut microbiota: The revolution has started (2020) (5)
- Obstacles to Donor Recruitment for Faecal Microbiota Transplantation: Experiences From the FOCUS Study: 650 (2014) (5)
- MMX™ Mesalamine Is Effective for the Maintenance of Ulcerative Colitis Remission in Both Left-Sided and Extensive Disease: 936 (2007) (5)
- The surgical treatment of severe idiopathic constipation (1987) (5)
- crossover study gastroparesis: a double blind, placebo controlled, Ghrelin enhances gastric emptying in diabetic (2008) (5)
- Systematic review: efficacy of escalated maintenance anti‐tumour necrosis factor therapy in Crohn's disease (2021) (5)
- Probiotic therapy for pouchitis and its endoscopic findings (2002) (5)
- Anin vitro electrophysiological study of the colon from patients with idiopathic chronic constipation (1992) (5)
- Effect of a novel prokinetic drug, RO93877, on bowel function and gastrointestinal transit in healthy volunteers (1997) (5)
- M1805 Defining, Diagnosing and Treating Constipation: Attitudes Among Gastroenterologists and General Practitioners - Results of a Three Country Survey (2008) (4)
- Strain population structure varies widely across bacterial species and predicts strain colonization in unrelated individuals (2020) (4)
- P837 The common food additives sodium sulfite and polysorbate 80 have a profound inhibitory effect on the commensal, anti-inflammatory bacterium Faecalibacterium prausnitzii: the ENIGMA study (2019) (4)
- Surgical management of hereditary pancreatitis: report of a case and presentation of a new family. (1994) (4)
- A radiopaque marker technique for measuring gastrointestinal transit in subjects with an ileostomy (1996) (4)
- A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive. (2021) (4)
- Mesenteric dendritic cells from germ-free mice cause less T-cell stimulation but still induce α4β7 integrin (2007) (4)
- Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review. (2021) (4)
- Relationship between parity and anal manometry (1993) (4)
- Tu1282 First Prospective, Population-Based Inflammatory Bowel Disease Incidence Study in China - the Emergence of “Western” Disease (2012) (4)
- Su1318 Intestinal Resection in Crohn's Disease Is Associated With Significant and Durable Improvement in Health Related Quality of Life Although to a Lesser Extent in Women and Smokers. Results From the POCER Study (2014) (4)
- Specialist Nurses in Gastroenterology (2002) (4)
- T1131 Steroid-Free Remission Over 2 Years in Crohn's Patients Receiving Adalimumab: the Open-Label Extension of the CHARM Trial (2008) (4)
- MMX™ mesalamine Therapy for the Induction of Remission Beyond 8 Weeks: How Long Before Symptom Resolution? (2008) (4)
- Treatment with anti-TNFA antibody reduces expression of CD40 on lamina propria dendritic cells—an early and central step in reducing T cell driven inflammation (2000) (4)
- An analysis of 65 patients with fecal incontinence due to obstetric injury (2003) (4)
- P342 Adalimumab prevents post-operative Crohn's disease recurrence and is superior to thiopurines: E (2012) (4)
- 312 The First Validated Post-Operative Endoscopic Crohns Disease Index: The POCER Index. Identification of Key Endoscopic Prognostic Factors (2016) (4)
- Sacral nerve stimulation for idiopthic slow transit constipation (2000) (3)
- Controlled clinical trial of ranitidine in bleeding peptic ulcer. (1986) (3)
- Prospective assessment of interobserver agreement for endoanal MRI in fecal incontinence (2001) (3)
- W1228 Prospective Scheduled Magnetic Resonance Imaging (MRI) to Guide Perineal Crohn's Fistula Treatment with Infliximab, Adalimumab and Thalidomide (2008) (3)
- Early surgical intervention in ulcerative colitis (2004) (3)
- Immune response to food in Crohn's diseae: In vivo and in vitro assessment (1998) (3)
- The results of stoma formation in severe idiopathic constipation (1992) (3)
- Motility and functional diseases of the large intestine (1993) (3)
- Biofeedback, not laxatives, improves symptoms, transit and autonomic tone in functional constipation (2003) (3)
- Post-Operative Crohn's Disease Recurrence: Impact of Endoscopic Monitoring and Treatment Step-up on Outcome (2011) (3)
- Development and Validation of Surveys to Estimate Food Additive Intake (2020) (3)
- The gut microbiota and gut disease (2021) (3)
- Prevalence of genito‐urinary symptoms in patients with disordered defecation (1994) (3)
- DOP81 Utility of a simple blood test for mucosal healing monitoring is accurate in post-operative Crohn’s disease (2019) (3)
- Microscopic colitis: Widening the definition (1995) (3)
- Fundal gastritis as a potential cause of reflux oesophagitis. (2000) (3)
- Speed of onset of oesophageal acid reduction with different proton‐pump inhibitors in patients with reflux oesophagitis (1998) (3)
- W1162 Corticosteroids Increase Interleukin-10 and Inhibit Interleukin-12p40 Production By Intestinal Dendritic Cells in Acute Ulcerative Colitis - Novel Mechanisms of Therapy (2008) (3)
- The small intestine and colon (1993) (3)
- Motility and functional diseases including diverticular disease (1992) (3)
- W1201 Production of IL-10 By Colonic Dendritic Cells Is Associated with Higher Concentrations of Faecal Microbiota in Patients with Active Crohn's Disease (2008) (3)
- Su1994 – The Common Food Additives Sodium Sulfite and Polysorbate 80 Have a Profound Inhibatory Effect on the Commensal, Anti-Inflammatory Bacterium Faecalibacterium Prausnitzii. the Enigma Study (2019) (3)
- Prospective Evaluation of Early Post-Operative Crohn's Recurrence in the Presence of Optimal Drug Therapy – Is Endoscopic Evaluation Worthwhile? (2011) (2)
- MMX Mesalamine Is Well Tolerated in Patients with Active Mild-to-Moderate Ulcerative Colitis: Pooled Analysis of Adverse Events from Three Randomized Studies (2006) (2)
- T1217 A Novel Population of CD56+ HLA-DR+ Colonic Lamina Propria Cells Is Associated with Inflammation in Ulcerative Colitis (2008) (2)
- Non-invasive Serological Monitoring for Crohn’s Disease Postoperative Recurrence (2022) (2)
- P043 Long-Term Steroid-Free Remission in Crohn's Patients Receiving Adalimumab: The Charm Trial (2008) (2)
- Long-Term Remission Rates in Patients with Mild-to-Moderate Ulcerative Colitis Who Require an MMX™ Mesalamine Dose Increase To Induce Initial Remission: 937 (2007) (2)
- A winking anus may signify spinal injury (2001) (2)
- Determinants of long‐term function and general well‐being in patients with an ileoanal pouch (2020) (2)
- Neuropeptides in the internal anal sphincter in neurogenic faecal incontinence (1993) (2)
- PROBIOTIC BACTERIAL DNA INDUCES INTERLEUKIN-10 PRODUCTION BY HUMAN DENDRITIC CELLS VIA TOLL-LIKE RECEPTOR-9 (2012) (2)
- Once- or Twice-Daily MMX™ Mesalamine for the Maintenance of Remission of Mild or Moderate Ulcerative Colitis: 939 (2007) (2)
- 998 Faecal Calprotectin Is Superior to Faecal Lactoferrin and S100A12 As a Surrogate Marker for Post-Operative Crohn's Disease Endoscopic Recurrence. Prospective Longitudinal Endoscopic Validation. Results From the POCER Study (2014) (2)
- P300 Crohn’s Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. The STRIDENT Randomised Controlled Trial (2021) (2)
- P083 - Steroid-free remission in patients with Crohn's disease who received adalimumab therapy for at least 3 years: long-term results from CHARM (2009) (2)
- MMX Mesalamine, a Novel Formulation of 5-ASA, Effectively Induces the Remission of Active Mild-to-Moderate Ulcerative Colitis in Men and Women: 1103 (2006) (2)
- Impact of Steroid Discontinuation on Health Care Resource Utilization in Crohn's Disease: 890 (2007) (2)
- DOP064 Faecal calprotectin is superior to faecal lactoferrin and S100A12 (2014) (2)
- Long-Term Adalimumab Treatment Is Associated with Sustained Fistula Healing in Patients with Moderate to Severe Crohnʼs Disease: 1067 (2008) (2)
- Serotonin, but not noradrenaline, levels are increased in the circular muscle and mucosa of the sigmoid colon from patients with severe idiopathic constipation (1989) (2)
- Probiotic bacteria induce maturation and modulate cytokine production by human dendritic cells (2003) (2)
- 597 Serological Antibodies for the Prediction of Post-Operative Recurrent Crohn's Disease Results From the POCER Study (2015) (2)
- Gut-focussed behavioural treatment (biofeedback) for constipation and faecal incontinence in patients with Multiple Sclerosis (2000) (2)
- Four week treatment of metronidazole and ciprofloxacin markedly decreases refractory pouchitis and improves the quality of life (2001) (2)
- Antagonist: Early surgical intervention in ulcerative colitis. (2004) (2)
- P124 Sustainability of Adalimumab in Improving the Quality of Life of Patients with Fistulizing Crohn's Disease: 2-Year Data from Charm (2008) (2)
- Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study (2022) (2)
- Modification of host cell function by normal flora – a molecular perspective (2002) (2)
- T2020 No Clinical Benefit of Prebiotics in the Treatment of Active Crohn's Disease: A Double-Blind, Randomised, Placebo-Controlled Trial (2010) (2)
- M1146 Long-Term Outcome and Adverse Events in Crohn's Disease Patients Treated with Infliximab At a Single Tertiary Referral Center Over 9 Years (2008) (2)
- Acute hepatitis due to etretinate (1988) (2)
- MMX mesalamine for providing remission of active mild-to-moderate ulcerative colitis: An evidence-based medicine analysis: P-0049. (2007) (2)
- P834 Proteus is a key candidate in the pathogenesis of Crohn’s disease: mucosa, stool genomics and functional analysis: the ENIGMA study (2019) (2)
- S1063 Sustained Improvement in Quality of Life for Patients with Fistulizing Crohn's Disease Treated with Adalimumab: 3-Year Data from CHARM (2009) (2)
- P834 Proteus is a key candidate in the pathogenesis of Crohn’s disease: mucosa, stool genomics and functional analysis: the ENIGMA study (2019) (2)
- Challenges in functional bowel disease. (2001) (2)
- Sa2057 Probiotic Bacteria VSL#3 Alter Visceral Sensitivity and Mucosa-Associated Intestinal Microbiota in Patients With Irritable Bowel Syndrome (2012) (2)
- The Effect of Prolonged Therapy with MMX™ Mesalamine in Patients with Acute, Mild-to-Moderate Ulcerative Colitis: 940 (2007) (2)
- MMX Mesalamine for the Treatment of Active Mild-to-Moderate Ulcerative Colitis: An Evidence-Based Medicine Analysis (2006) (2)
- P019 LONG-TERM FISTULA HEALING AND RESPONSE WITH ADALIMUMAB TREATMENT: 2-YEAR DATA FROM CHARM INCLUDING 1-YEAR OPEN-LABEL EXTENSION (2008) (2)
- P057 MMX Mesalazine is an Effective Treatment for Men And Women With Mild-To-Moderate, Active Ulcerative Colitis (2007) (2)
- Functional disorders of the colon and anorectum (1995) (2)
- Topical phenylephrine increases anal sphincter resting pressure: A possible treatment for faecal incontinence (1998) (2)
- P186 Intestinal Cytokine Production by Dendritic Cells in Acute Ulcerative Colitis - An Immunoregulatory Role? (2007) (1)
- Su1301 Incidence and Phenotype of Inflammatory Bowel Disease From 2012-2013 Across 9 Countries in Asia: Results From the 2012 Access Inception Cohort (2015) (1)
- Accuracy of point‐of‐care intestinal ultrasound for Crohn's disease (2020) (1)
- Induction of mucosal healing in mild-to-moderate ulcerative colitis in patients treated with MMX mesalamine: established versus newly diagnosed disease: P-0096. (2009) (1)
- The host response to the normal intestinal flora (2002) (1)
- Crohn's Disease Phenotype at Diagnosis is More Severe in the East (China) Than the West (Australia) and is Managed Differently. (2011) (1)
- How to treat: Faecal incontinence (2003) (1)
- DOP086 Intestinal resection in Crohn's disease is associated with significant and durable improvement in health related quality of life although to a lesser extent in women and smokers. Results from the POCER study (2014) (1)
- MMX mesalamine for providing remission of active mild-to-moderate ulcerative colitis: An evidence-based medicine analysis (2007) (1)
- 4 CROHN'S DISEASE PATHOBIONT ENTEROBACTERIACEAE GROWTH IS MODULATED BY FOOD ADDITIVES AND OXYGEN AVAILABILITY: FACTORS IN PATHOPHYSIOLOGY AND RECURRENCE. THE ENIGMA STUDY. (2020) (1)
- Occult anal sphincter damage following manual disimpaction demonstrated by anal ultrasonography (1994) (1)
- Defining optimal care for functional gut disorders - Multi-disciplinary versus standard care: A randomized controlled trial protocol. (2019) (1)
- Imaging predicts the results from anterior external anal sphincter repair following obstetric trauma (2001) (1)
- Dendritic cells (DC) differ between the small intestine and colon: Expression of the chemokine receptor CCR7 suggests that small intestine DC traffic constitutively, colonic DC only in inflammation (2003) (1)
- NOTICE OF WITHDRAWAL (2006) (1)
- Editorial: treating strictures in inflammatory bowel disease (2018) (1)
- Sa1913 CONSENSUS GUIDELINES FOR THE REGULATION, PRODUCTION AND USE OF FECAL MICROBIOTA TRANSPLANTATION IN CLINICAL PRACTICE (2020) (1)
- 604 FOOD ADDITIVES ENHANCE PRO-INFLAMMATORY BACTERIAL GROWTH IN CROHN'S DISEASE MUCOSA-ASSOCIATED MICROBIOTA. THE ENIGMA STUDY. (2021) (1)
- Gut microbiota bacterial strain richness is species specific and limits therapeutic engraftment (2022) (1)
- Optimal delivery of care for functional gastrointestinal disorders: Randomized controlled trial of standard gastroenterologist-only care versus multidisciplinary care (MANTRA study) (2019) (1)
- 264 What Causes Recurrence of Crohn's Disease After Intestinal Resection? A Prospective Evaluation of Microbiota, Smoking and Anti-TNF Therapy. Results From the POCER Study (2015) (1)
- Impact of long-term Adalimumab treatment on fistula healing in patients with moderate to severe Crohnʼs Disease: P-0072. (2008) (1)
- P849 Urease-positive proteobacteria in Crohn’s disease identified by novel ex vivo mucosal microbe culture combined with metagenomic sequencing (MC-MGS): the ENIGMA study (2019) (1)
- Sa513 FOOD AS A RISK FACTOR FOR THE DEVELOPMENT AND PERPETUATION OF CROHN'S DISEASE.AN INTERNATIONAL CASE-CONTROL STUDY OF FOOD AND FOOD ADDITIVE INTAKE FROM BIRTH TILL NOW. THE ENIGMA STUDY. (2021) (1)
- Immune sensitization to food and bacteria in Crohn's disease (1998) (1)
- Is targeting locus of control a desirable outcome of biofeedback in functional constipation (2007) (1)
- S1328 Patients Can Self-Manage Their Stimulant Laxative Dose to Achieve Effective Relief of Chronic Constipation, as Demonstrated in Two Randomized Trials (2010) (1)
- Induction of clinical and endoscopic remission in mild-to-moderate ulcerative colitis in patients treated with MMX® mesalamine: established versus newly diagnosed disease: P-0092. (2009) (1)
- W1114 Methotrexate in Thiopurine Refractory Crohn's Disease - a Retrospective Cohort Study (2009) (1)
- OP019 In faecal microbiota transplantation (FMT) for ulcerative colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short-chain fatty acid production are associated with remission (FOCUS study) (2018) (1)
- P-107 Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients with Crohn's Disease (2016) (1)
- P260 Point of Care Ultrasound (POCUS) when performed by gastroenterologists with 200 supervised scans is accurate and clinically useful for patients with Crohn’s disease (2018) (1)
- Anorectal physiology and pathology. (1991) (1)
- Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era (2020) (1)
- Post-Operative Crohn's Disease Recurrence is Associated with Specific Changes in the Faecal Microbiome and Potential Pathogenic and Protective Roles (2017) (1)
- Comparison of the risk of Crohn's disease postoperative recurrence between modified Rutgeerts score i2a and i2b categories: an individual patient data meta-analysis. (2022) (1)
- Modification of the intestinal flora (2002) (1)
- 409 RANDOMISED TRIAL OF MULTI-DISCIPLINARY VERSUS STANDARD GASTROENTEROLOGIST CARE FOR FUNCTIONAL GASTROINTESTINAL DISORDERS (2020) (1)
- Tu1847 – Urease-Positive Proteobacteria in Crohn's Disease Identified by Novel Ex-Vivo Mucosal Microbe Culture Combined with Metgenomic Sequencing (MC-MGS). the Enigma Study (2019) (1)
- Topical application of a nitric oxide donor reduces internal anal sphincter tone Therapeutic implications (1993) (1)
- Rectal sensation, the rectoanal reflex, and faecal incontinence (1988) (1)
- 459 CROHN'S DISEASE STRICTURES RESPOND TO DRUG TREATMENT AND TREAT-TO-TARGET INTENSE COMBINATION THERAPY IS MORE EFFECTIVE THAN STANDARD ANTI-TNF THERAPY. THE STRIDENT RANDOMISED CONTROLLED TRIAL. (2021) (1)
- T1218 Intestinal Dendritic Cells in Ulcerative Colitis Have Altered CD103 (Alpha-E) Expression - in Support of Dysregulation in Gut-Homing (2008) (1)
- Smokers with active crohn's disease have differences in the concentration and proportion of key bacterial groups of the faecal microbiota (2008) (1)
- Processed Food as a Risk Factor for the Development and Perpetuation of Crohn’s Disease—The ENIGMA Study (2022) (1)
- Evaluation of Helicobacter pyloni in reflux oesophagitis and Barrett's oesophagus (1)
- Mo1799 – Utility of a Simple Blood Test for Mucosal Healing Monitoring is Accurate in Post-Operative Crohn’s Disease (2019) (1)
- Abdominal and pelvic abscesses in Crohn's disease: Results of non-invasive and surgical management (1995) (1)
- Letter: tofacitinib in biologic‐experienced ulcerative colitis—a single‐centre real‐world experience in Australia (2021) (1)
- Intestinal homing memory T lymphocytes produce increased tumour necrosis factor-alpha during relapse of ulcerative colitis: Prospective study of patients in remission and at relpase (2003) (1)
- P006 - Sustainability of adalimumab in improving the quality of life of patients with fistulizing Crohn's disease: 3-year data from CHARM (2009) (1)
- Pelvic floor behavioral treatment for fecal incontinence and constipation in quiescent inflammatory bowel disease (2022) (1)
- A pharmaceutical composition for the treatment of fecal incontinence (1997) (0)
- Dendritic cell (DC) regulation of natural killer T cells may be altered in Crohns disease inflammation: Loss of MHC class I-like CD1 molecules from mucosal dendritic cells (2003) (0)
- What causes post-operative Crohn's disease recurrence? Evaluation of gut microbiota, anti-TNF non-response and smoking (2015) (0)
- P772 Development and validation of tools to assess food additive intake: the ENIGMA study (2019) (0)
- Adalimumab Therapy maintains meaningful rates of steroid-free remission in patients with Crohnʼs Disease for up to 3 Years of Therapy: Results From an Open-Label Extension of CHARM: P-0117. (2009) (0)
- DRUG MANAGEMENT OF ULCERATIVE COLITIS. REPLY (1992) (0)
- 552: DEEP CHARACTERIZATION OF THE MUCOSA-ASSOCIATED MICROBIOTA IN ASIAN AND WESTERN POPULATIONS REVEALS ACIDAMINOCOCCUS OCCUPIES A KEY NICHE IN THE NITROGEN ECONOMY OF CROHN'S DISEASE. THE ENIGMA STUDY (2022) (0)
- experience . in inflammatory bowel disease : 27 years of Bone marrow toxicity caused by azathioprine (2006) (0)
- Sa1143 Need for Recurrent Resection and Complex Phenotype Are Associated With a Specific Antibody Signature in Crohn's Disease Patients Undergoing Resection; Smoking Is Not Associated With Prevalent Antibodies; Prognostic and Mechanistic Implications (2015) (0)
- P458 the microbiota in crohn's disease and health is it the same in the east and west? the effects of geography, ethnicity and disease on microbiota (2012) (0)
- 219 Incidence and Phenotype At Diagnosis of Inflammatory Bowel Disease Across 9 Countries in Asia-Pacific (2013) (0)
- Genetics of Inflammatory Bowel Disease in Asia: Systematic Review and Meta-Analysis (2011) (0)
- Tu1255 MICROBIOTA AND VIRUENCE FACTORS ASSOCIATED WITH CROHN'S DISEASE RECURRENCE REVEALED AT STRAIN-LEVEL RESOLUTION BY NOVEL COMBINATION OF MICROBE CULTURE AND METAGENOMIC SEQUENCING (MC-MGS). THE ENIGMA STUDY (2020) (0)
- Production of interleukin-10 by human intestinal dendritic cells is upregulated by probiotic bacteria (2003) (0)
- The structure, function, and pathology of the thyroid gland (0)
- P185 Increased Gut Plasmacytoid Dendritic Cells in Acute Ulcerative Colitis - Key Mediators Of Immunity and Inflammation? (2007) (0)
- S1320 Multi-Center, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Sodium Picosulfate (SPS) in Patients With Chronic Constipation (2010) (0)
- Response to Savoye and Savoye-Collet (2010) (0)
- Patey Prize 02 (2009) (0)
- Signaltrassduction-factor NFκB p65 is activated in patients with chronic relapsing pouchitis through probiotic therapy although healing occurs (2001) (0)
- Reply: To PMID 25167986. (2015) (0)
- Reply (1993) (0)
- Clinical outcomes among elderly patients with inflammatory bowel disease. (2022) (0)
- A cc ep te d A rti cl e PARENT HOSTILITY AND SPIN-OUT PERFORMANCE (2013) (0)
- T1350 Pudendal Nerve Stimulation for Bowel Dysfunction Secondary to Spinal Cord Injury (2010) (0)
- P316 - TNF-α production and differential release of Th1/Th2 cytokines detected in colonic tissues of inflammatory bowel disease patients but not controls (2009) (0)
- Tu1289 Preventing Crohn's Disease Recurrence After Resection With Adalimumab: Role of Drug and Anti-Drug Antibody Levels (2015) (0)
- Mo1745 The Microbiota in Crohn's Disease and Health - is it the Same in the East and West? the Effects of Geography, Ethnicity and Disease on Microbiota (2012) (0)
- 426 FURTHER EVIDENCE THAT PROTEUS MIRABILIS IS A KEY BACTERIUM IN CROHN'S DISEASE PATHOGENESIS. THE ENIGMA STUDY. (2020) (0)
- Food, prebiotics and bacteria (2002) (0)
- Behavioural therapy (biofeedback) for solitary rectal ulcer syndrome improves symptoms, mucosal blood flow and can produce healing (2003) (0)
- Gut-specific autonomic testing can be used to predict bowel dysfunction in spinal cord injury patients (1998) (0)
- Bonemarrow toxicity caused byazathioprine in inflammatory bowel disease: 27years ofexperience (2017) (0)
- Clinical risk stratification accurately predicts development of endoscopic recurrence after Crohn (2012) (0)
- RISK FACTORS FOR SUBSEQUENT INTESTINAL RESECTIONS IN PATIENTS WITH CROHN'S DISEASE (2008) (0)
- Pharmaceutical composition comprising a topical cholinergic agent or a calcium channel blocker (1998) (0)
- PP1700 大腸憩室症におけるMatrix MetalloproteinaseとTissue Inhibitor of Metalloproteinaseの検討 (2001) (0)
- Subject Index Vol. 60, 1999 (1999) (0)
- Summary and observations (2002) (0)
- T1162 The Concentration and Proportion of Key Bacterial Groups of the Faecal Microbiota Are Different Between Smokers and Non-Smokers with Active Crohn's Disease (2008) (0)
- Inflammatory Bowel Diease: East Meets West: Falk Symposium 198, Shenzhen, September 2015: Official Congress Report (2016) (0)
- P749 Crohn’s disease stricture response and resolution with adalimumab therapy demonstrated with intestinal ultrasound. The STRIDENT randomised trial (2023) (0)
- Tegaserod is safe and well tolerated in patients with chronic constipation: results from a 12-week multinational study (2003) (0)
- S1750 Distinct Cytokine Patterns from Multiplex Profiles of Patients with Inflammatory Bowel Disease, Functional Bowel Disorder and Healthy Controls (2009) (0)
- DOP49 Metagenomic Characterisation of The Colonic Mucosa-Associated Microbiota Reveals Novel Microbes and Communities in Health and Crohn’s disease. The ENIGMA study (2023) (0)
- DOP34 Comparison of the risk of clinical recurrence after ileocolonic resection for Crohn’s Disease for modified Rutgeerts’ score i2a and i2b categories: Individual patient data meta-analysis (2022) (0)
- P056 Number Needed To Treat With MMX Mesalazine For One Patient With Mild-To-Moderate Ulcerative Colitis To Achieve Remission (2007) (0)
- M1236 Prevalence of Self-Defined Constipation and Laxative Use Among Adults from South America and Asia (2009) (0)
- Co-stimulatory molecule expression on gut dendritic cells (DC) is upregulated in inflamed tissue from Crohn's disease - a possible early and central step in driving T cell activation (2000) (0)
- 96. Dual isotope gastric emptying and colonic transit: development of a scanning protocol (1992) (0)
- New therapeutic possibilities in inflammatory bowel disease. (2001) (0)
- M1804 Pharmacist Attitudes About Constipation and Its Treatment: A Survey Conducted in Three Countries (2008) (0)
- P053 Prolonged Therapy with MMX™ Mesalazine in Patients with Acute, Mild-to-Moderate Ulcerative Colitis Who Fail Initial Mesalazine Treatment may Avoid the Need for Therapeutic Escalation (2008) (0)
- OC-011 Demographic, clinical and genetic factors associated with dysbiosis in patients with active Crohn's disease (2010) (0)
- Symptom resolution with MMX® mesalazine in patients with mild-to-moderately active ulcerative colitis who are newly diagnosed or have been living with their disease for a prolonged period (2010) (0)
- P511 Radiological outcomes in perianal fistulising Crohn’s disease (2019) (0)
- P669 Improving Crohn’s disease stricture dilation outcome: Effect of repeated dilation, needle knife stricturotomy, and ongoing active inflammation (2023) (0)
- O-027: Sustainability of adalimumab in fistula healing and response: 2-year data from CHARM and an open-label extension follow-up study (2008) (0)
- Loss of mucosal CD1a+ dendritic (antigen presenting) cells in inflammatory bowel disease (1998) (0)
- 261 – Proteus is a Key Candidate in the Pathogenesis of Crohn's Disease: Mucosa, Stool Genomics and Functional Analysis: the Enigma Study (2019) (0)
- DOP85 Crohn's Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. Two year results of the STRIDENT Randomised Controlled Trial (2023) (0)
- Sa1387 Long-Term Follow-Up of a Prospective, Open, Multicenter Cohort Study of Sacral Neuromodulation for Intractable Constipation (2015) (0)
- P312 Thiopurine metabolite testing in inflammatory bowel disease (2014) (0)
- P852 Characterisation of Crohn’s disease mucosa-associated microbiota by a novel combination of microbe culture and metagenomic sequencing (MC-MGS): the ENIGMA study (2019) (0)
- P575 Simple novel tacrolimus enemas are very effective in severe refractory proctitis (2019) (0)
- Author's response (2010) (0)
- P320 6-Thioguanine nucleotide levels are associated with trough levels of infliximab and adalimumab in Inflammatory Bowel Disease patients on combination therapy: A retrospective multicentre study (2022) (0)
- P015 THALIDOMIDE IN LUMINAL AND FISTULISING CROHN'S DISEASE RESISTANT TO STANDARD THERAPIES (2007) (0)
- Intestinal bacteria and mechanisms of disease (2002) (0)
- OC-003 No clinical benefit of prebiotics in the treatment of active Crohn's disease: a double-blind, randomised, placebo-controlled trial (2010) (0)
- Subject Index Vol. 57, 1996 (1996) (0)
- P409 Endoscopic and histological activity is associated with non-response to biologic therapy in ulcerative colitis (2020) (0)
- MMXTM mesalamine for the maintenance of remission in mild-to-moderate ulcerative colitis: P-045. (2008) (0)
- P523 Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn’s disease (2019) (0)
- Prospective evaluation of the relationship between stress and relapse in ulcerative colitis. (2008) (0)
- Bowelfunction andtransit rateduring the menstrual cycle (1989) (0)
- Pharmaceutical compositions for the treatment of fecal incontinence and analklöe (1997) (0)
- P925 Deep functional assessment of the colonic mucosa-associated microbiota in Crohn's disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIGMA study (2023) (0)
- Kamm with a functional gut disorder of activity of extrinsic gut innervation in patients Relationship between psychological state and level (2001) (0)
- Adalimumab induction therapy achieves clinical remission and response in chinese patients with Crohn's Disease (2015) (0)
- SYMPOSIUM ON FAECAL INCONTINENCE (2001) (0)
- Manometry, Electromyography and Other Functional Pelvic Floor Tests (1993) (0)
- Prospective Evaluation of the Mucosa-Associated Microbiota After “Curative” Crohn's Resection Reveals Incomplete Return to “Normal” and Association of Bacteroides With Protection From Disease Recurrence (2011) (0)
- P766 Practical application of evidence-based dietary therapy into inflammatory bowel disease care shows high patient satisfaction, compliance, and efficacy. The Delectable Program (2023) (0)
- W1357 Cross-Sectional Study On the Correlation Between Pre-Operative Azathioprine and Myenteric Plexitis in the Proximal Resection Margins and Affected Crohn's Disease Segment (2008) (0)
- Gastro-esophageal reflux and motility: implications for management. (1994) (0)
- Anti-TNF therapy: a fulfilment of great expectations (2002) (0)
- Ulcerative Colitis at Diagnosis is More Extensive Anatomically in the East (China) Than the West (Australia) and is Managed Differently. (2011) (0)
- Constipation. Kamm M.A., Lennard‐Jones J.E., eds. Wrightson Biomedical Publishing, 1994 (1995) (0)
- 534 – Mri is Highly Predictive of the Clinical Course of Crohn's Disease Strictures (2019) (0)
- P059 MMX MESALAZINE IS AN EFFECTIVE TREATMENT FOR ACTIVE, MILD-TO-MODERATE UC REGARDLESS OF PRIOR 5-ASA USE: A POOLED ANALYSIS OF TWO PLACEBO-CONTROLLED, PHASE III TRIALS (2007) (0)
- PTH-034 Stress-induced immunomodulation in irritable bowel syndrome suppresses Th1 and Th2 cytokines (2010) (0)
- Book review (2005) (0)
- Su1581 Endoscopic Outcomes After Ileo-Caecal Resection for Crohn's Disease: A Prospective Single Tertiary Centre Study (2011) (0)
- P538 Suboptimal disease control is common in patients with Crohn’s perianal fistulas with capacity to optimise medical and surgical treatment in real-world experience: A cross-sectional analysis of baseline disease characteristics in the FINESS study (2023) (0)
- Tu1869 – Characterization of Crohn's Disease Mucosa-Associated Microbiota by a Novel Combination of Microbe Culture and Metagenomic Sequencing (MC-MGS). the Enigma Study (2019) (0)
- IBD Basic Science (2022) (0)
- Clinical features and outcomes of adult idiopathic megarectum (2023) (0)
- 397: FOOD ADDITIVES INTAKE IS ASSOCIATED WITH MICROBIOME DYSBIOSIS AND SPECIFIC PRO-INFLAMMATORY BACTERIAL CHANGES IN CROHN'S DISEASE. THE ENIGMA STUDY. (2022) (0)
- Colonic motility and functional diseases (1991) (0)
- Abnormalities of the Neural Control of the Internal Anal Sphincter in Idiopathic Faecal Incontinence (1992) (0)
- Endoscopic and histological disease activity in ulcerative colitis is associated with nonresponse to biological therapy (2019) (0)
- Crohn’s disease: towards improving postsurgical outcomes. (2013) (0)
- Impact of steroid discontinuation on health care resource utilization in Crohnʼs disease: P-011. (2008) (0)
- Arthropathy of inflammatory bowel disease and the effect of restorative proctocolectomy (1995) (0)
- Approach to Dietary Restriction in Irritable Bowel Syndrome. (2021) (0)
- Composition pharmaceutique destinee au traitement de l'incontinence fecale et du prurit anal (1997) (0)
- EP1308: 6-THIOGUANINE NUCLEOTIDE LEVELS AND ANTI-TNFα TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A RETROSPECTIVE MULTICENTRE STUDY (2022) (0)
- Satisfaction with therapy among patients treated with MMXTM mesalamine for maintenance of remission in patients with mild-to-moderate ulcerative colitis: P-044. (2008) (0)
- MRI Guided Biologic Therapy for Crohn's Perianal Fistulae: 3 Year Follow up Data (2011) (0)
- Intestine mucosal IL‐22 is reduced following oral probiotic administration: implications on epithelial barrier repair (2013) (0)
- Crohn ' s disease . Lower gastrointestinal malignancy in (2006) (0)
- Utility of a simple blood test for mucosal healing monitoring is accurate in postoperative Crohn's disease (2019) (0)
- Mo1926 - Donor Characteristics and Clinical Outcomes of Fecal Microbiota Transplantation: A Systematic Review of Clinical Studies Published Up to 2017 (2018) (0)
- Letter: management of post‐operative Crohn's disease ‐ thiopurines vs adalimumab– authors' reply (2016) (0)
- DOP48 Key Anti-Inflammatory Faecalibacterium prausnitzii is Heterogeneous and Diverse in the East and West and in Health and Crohn’s disease. The ENIGMA study (2023) (0)
- P309 - Altered imprinting of lymphocyte homing by colonic dendritic cells in human ulcerative colitis (2009) (0)
- Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn's Disease. (2023) (0)
- Induction of remission with extended MMXTM mesalamine therapy: time to resolution of UC symptoms: P-0026. (2008) (0)
- Drug management of ulcerative colitis: Author's reply (1992) (0)
- A pharmaceutical preparation for the treatment of anal incontinence and anal itch (1997) (0)
- Probiotic Bacteria Differentially Modulate the Maturation and Cytokine Expression of Human Dendritic Cells (2003) (0)
- Plummer & Vinson of the Plummer-Vinson syndrome (1999) (0)
- visceral fat as a predictor of post‐operative recurrence of Crohn's disease—Authors’ reply (2017) (0)
- Mo1789 - The “Assurance” IBD Neoplasia Surveillance Software Guides Patient Management and Data Collection: Results from Asia-pacific (2018) (0)
- MMX mesalamine, a novel formulation, effectively induces remission of mild-tomoderate ulcerative colitis: a pooled analysis of two phase III studies: P-0079. (2007) (0)
- Tu1775 – The Nod2 Association with Cd-Associated Serological Markers is Modulated by Its Effect on Gut Microbiome (2019) (0)
- Reply (1997) (0)
- Prolonged MMX® mesalazine therapy in patients with acute, mild-to-moderate ulcerative colitis who fail initial mesalazine treatment may prevent a requirement for therapeutic escalation (2010) (0)
- DNA viruses inthepathogenesis ofsporadic chronic idiopathic intestinal pseudo-obstruction (1997) (0)
- P773 Post-operative Crohn's disease recurrence is associated with specific changes in the faecal microbiome - potential pathogenic and protective roles. (2017) (0)
- Tu1497: COMPARISON OF THE RISK OF CLINICAL RECURRENCE AFTER ILEOCOLONIC RESECTION FOR CROHN'S DISEASE FOR MODIFIED RUTGEERTS’ SCORE I2A AND I2B CATEGORIES: INDIVIDUAL PATIENT DATA META-ANALYSIS. (2022) (0)
- Physiology and Pathophysiology of Defaecation (1993) (0)
- P587 Intestinal ultrasound (IUS) and magnetic resonance imaging (MRI) for monitoring of response to therapy in luminal Crohn’s disease – a systematic review (2023) (0)
- The normal flora and techniques of identification (2002) (0)
- Sa533 NOVEL CHARACTERIZATION OF THE SECRETOMES OF CROHN'S DISEASE MUCOSA-ASSOCIATED MICROBIOTA, AND THEIR MODULATION OF INFLAMMATION THROUGH NF-κB SIGNALLING. THE ENIGMA STUDY. (2021) (0)
- Low failure to attend rates and increased clinic capacity with Telehealth: A highly effective outpatient model that should continue beyond the COVID‐19 pandemic (2020) (0)
- Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients With Crohnʼs Disease: 1874 (2015) (0)
- A six-month open label evaluation of CDP571, a humanized antibody to TNFa, in active Crohn's disease (2000) (0)
- Validation of the Inflammatory Bowel Disease Disk in clinical practice (2019) (0)
- P121 Long-Term Outcome and Adverse Events in Crohn's Disease Patients Treated with Infliximab at a Single Tertiary Referral Centre (2008) (0)
- constipation Sacral nerve stimulation for intractable (0)
- Association of Complete Spontaneous Bowel Movements (CSBM) and Symptom Improvement in Chronic Constipation (CC) Patients (PTS): 931 (2005) (0)
- FORTHCOMING ARTICLES MARCH 2010 (2009) (0)
- P558 Validation of the ‘IBD Disk’ in clinical practice (2020) (0)
- P166 THE EFFICACY OF MMX™ MESALAZINE AS THE SOLE MEDICATION FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS TREATED OVER 14-16 MONTHS (2008) (0)
- Letters Author's Reply (0)
- Manipulation of enteric flora in clinical practice (2005) (0)
- EP1283: NOVEL FAECAL MICROBIOME SIGNATURES AS NON-INVASIVE BIOMARKERS FOR DIAGNOSIS OF CROHN'S DISEASE AND AT-RISK POPULATIONS (2022) (0)
- Non-surgical of faecal incontinence (2001) (0)
- Dendritic Cells Migration and Maturation of Human Colonic (2001) (0)
- P158 Outcome of inflammatory bowel disease strictures (2018) (0)
- Reply: To PMID 25542620. (2015) (0)
- P195 MRI is predictive of, and anti-TNF treatment changes, the clinical course of Crohn's disease strictures (2019) (0)
- Contents Vol. 57, 1999 (1999) (0)
- Evaluation and management of ileal pouch-anal anastamosis (IPAA) complications in pregnancy, and the impacts of an IPAA on fertility. (2023) (0)
- COMPARISON OF TWO DIFFERENT METHODS FOR THE DETERMINATION OF 5-AMINOSALICYLIC ACID IN HUMAN INTESTINAL SAMPLES BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AND ELECTROCHEMICAL DETECTION (2008) (0)
- ASSURANCE: a multi-centre practical and systematised approach to colorectal cancer surveillance in patients with inflammatory bowel disease (2016) (0)
- Erratum: (Gastroenterology (1999) 166 (735-760)) (1999) (0)
- Tu1489: STRAIN-LEVEL RESOLUTION OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA REVEALS NOVEL TRANS-ETHNIC DIFFERENCES IN HEALTH AND CROHN'S DISEASE. THE ENIGMA STUDY. (2022) (0)
- P047 - Prospective assessment of the effect on quality of life of healing perineal Crohn's fistulas with anti-tumour necrosis factor therapy (2009) (0)
- Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study (2022) (0)
- Prospective Evaluation of the Mucosa-Associated Microbiota Using 454 Pyrosequencing at Crohn's Surgery and 6 Months Later Reveals Loss of Diversity and Specific Phyla Changes Associated With Disease Recurrence (2011) (0)
- Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn’s disease. The ENIGMA study (2023) (0)
- Authors' reply (2000) (0)
- Nurse-led, protocol-driven screening for hepatitis B virus before initiating biological therapy for chronic inflammatory disease is very effective (2019) (0)
- Pathogenesis of Crohn's disease (1992) (0)
- Escalating incidence of IBD in the East and West - Is the microbiota the key? impact of ethnicity, geography, and disease on the microbiota. The ENIGMA study (2013) (0)
- P265 Intestinal Dendritic Cells in Ulcerative Colitis Have Altered CD103 (α-E) Expression Supporting Dysregulation in Gut-Homing (2008) (0)
- Are biological drugs effective enough (2007) (0)
- Su1530 Narrow Band Imaging (NBI) Versus Chromoendoscopy for Dysplasia Detection in Colitis Surveillance: Double-Blind Comparison (2011) (0)
- Spontaneous production of pro-inflammatory cytokines by colonic biopsies is altered by treatment of Crohn's disease patients with anti-TNFa antibody (2000) (0)
- Comparison of Fecal In fl ammatory Markers in Crohn ’ s Disease (0)
- T2068 Suppression of TH1 and TH2 Cytokines in Patients With Irritable Bowel Syndrome- Evidence of a Chronic Stress Immunophenotype? (2010) (0)
- Urinary Bladdar Cancer In Jordan: An Epidemiologic Study (1981) (0)
- Both high-dose (4.8g/day) induction and low-dose (2.4g/day) maintenance therapy with MMXTM mesalamine have an excellent safety profile in patients with mild-to-moderate ulcerative colitis: P-028. (2008) (0)
- Steroid-Free remission in response to Adalimumab therapy over 2 years in patients with Crohnʼs Disease: Results From open-label extension of the CHARM trial: P-0075. (2008) (0)
- Book reviews (2004) (0)
- Therapeutic advances and issues of patient adherence in the treatment of ulcerative colitis (2007) (0)
- Editorial: visceral fat as a predictor of post‐operative recurrence of Crohn's disease—Authors’ reply (2017) (0)
- P589 Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis. (2017) (0)
- EP1273: PRACTICAL APPLICATION OF EVIDENCE-BASED DIETARY THERAPY INTO INFLAMMATORY BOWEL DISEASE CARE. PATIENT SATISFACTION, COMPLIANCE, AND EFFICACY. THE DELECTABLE PROGRAM. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michael A Kamm?
Michael A Kamm is affiliated with the following schools: